Konstan, Michael W.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Pulmonary exacerbations in cystic fibrosis: Young children with characteristic signs and symptoms

Warren E. Regelmann, Michael S. Schechter, Jeffrey S. Wagener, Wayne J. Morgan, David J. Pasta, Eric P. Elkin, Michael W. Konstan, for the Investigators of the Epidemiologic Study of Cystic Fibrosis

Journal:

Pediatric Pulmonology

Year:

2012

Language:

english

File:

PDF, 277 KB

english, 2012

2

Assessment and management of agitation in psychiatry: Expert consensus

Garriga, Marina, Pacchiarotti, Isabella, Kasper, Siegfried, Zeller, Scott L., Allen, Michael H., Vázquez, Gustavo, Baldaçara, Leonardo, San, Luis, McAllister-Williams, R. Hamish, Fountoulakis, Konstan

Journal:

The World Journal of Biological Psychiatry

Year:

2016

Language:

english

File:

PDF, 3.00 MB

english, 2016

3

A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial

Boyle, Michael P, Bell, Scott C, Konstan, Michael W, McColley, Susanna A, Rowe, Steven M, Rietschel, Ernst, Huang, Xiaohong, Waltz, David, Patel, Naimish R, Rodman, David

Journal:

The Lancet Respiratory Medicine

Year:

2014

Language:

english

File:

PDF, 423 KB

english, 2014

4

Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)

McKone, Edward F, Borowitz, Drucy, Drevinek, Pavel, Griese, Matthias, Konstan, Michael W, Wainwright, Claire, Ratjen, Felix, Sermet-Gaudelus, Isabelle, Plant, Barry, Munck, Anne, Jiang, Ying, Gilmarti

Journal:

The Lancet Respiratory Medicine

Year:

2014

Language:

english

File:

PDF, 406 KB

english, 2014

5

Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology

Michael W. Konstan, Melvin Berger

Journal:

Pediatric Pulmonology

Year:

1997

Language:

english

File:

PDF, 113 KB

english, 1997

6

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

Wainwright, Claire E., Elborn, J. Stuart, Ramsey, Bonnie W., Marigowda, Gautham, Huang, Xiaohong, Cipolli, Marco, Colombo, Carla, Davies, Jane C., De Boeck, Kris, Flume, Patrick A., Konstan, Michael W

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 567 KB

english, 2015

7

Long-term Effects of Pregnancy and Motherhood on Disease Outcomes of Women with Cystic Fibrosis

Schechter, Michael S., Quittner, Alexandra L., Konstan, Michael W., Millar, Stefanie J., Pasta, David J., McMullen, Ann

Journal:

Annals of the American Thoracic Society

Year:

2013

Language:

english

File:

PDF, 735 KB

english, 2013

8

AI Theory and Practice: A Discussion on Hard Challenges and Opportunities Ahead

Horvitz, Eric, Getoor, Lise, Guestrin, Carlos, Hendler, James, Konstan, Joseph, Subramanian, Devika, Wellman, Michael, Kautz, Henry

Journal:

Year:

2010

Language:

english

File:

PDF, 200 KB

english, 2010

9

Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis

David E. Geller, Howard Eigen, Stanley B. Fiel, Andrew Clark, André P. Lamarre, Charles A. Johnson, Michael W. Konstan

Journal:

Pediatric Pulmonology

Year:

1998

Language:

english

File:

PDF, 71 KB

english, 1998

10

Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada

Wayne J. Morgan, Steven M. Butler, Charles A. Johnson, Andrew A. Colin, Stacey C. FitzSimmons, David E. Geller, Michael W. Konstan, Michael J. Light, Harvey R. Rabin, Warren E. Regelmann, Daniel V. Sc

Journal:

Pediatric Pulmonology

Year:

1999

Language:

english

File:

PDF, 341 KB

english, 1999

11

Patterns of medical practice in cystic fibrosis: Part II. Use of therapies

Michael W. Konstan, Steven M. Butler, Daniel V. Schidlow, Wayne J. Morgan, Joanne R. Julius

Journal:

Pediatric Pulmonology

Year:

1999

Language:

english

File:

PDF, 129 KB

english, 1999

12

Patterns of medical practice in cystic fibrosis: Part I. Evaluation and monitoring of health status of patients

Michael W. Konstan, Steven M. Butler, Daniel V. Schidlow, Wayne J. Morgan, Joanne R. Julius

Journal:

Pediatric Pulmonology

Year:

1999

Language:

english

File:

PDF, 39 KB

english, 1999

13

The bronchoscope–flexible and rigid–in children. Edited by Angelo Barbato, Louis Landau, Pierre Scheinmann, John Warner, and Maximilian Zach. Mogliano Veneto-Treviso, Italy: The Arcari Editore, 1995, 96 pp

Michael W. Konstan

Journal:

Pediatric Pulmonology

Year:

1996

Language:

english

File:

PDF, 256 KB

english, 1996

14

A two-dimensional magnetic hybrid material based on intercalation of a cationic Prussian blue analog in montmorillonite nanoclay

Dimitrios Gournis, Christina Papachristodoulou, Enrico Maccallini, Petra Rudolf, Michael A. Karakassides, Dimitrios T. Karamanis, Marie-Hélène Sage, Thomas T.M. Palstra, Jean-François Colomer, Konstan

Journal:

Journal of Colloid and Interface Science

Year:

2010

Language:

english

File:

PDF, 787 KB

english, 2010

15

Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis

Richard C. Ahrens, Thomas A. Standaert, Janice Launspach, Seung-Ho Han, Mary E. Teresi, Moira L. Aitken, Thomas J. Kelley, Kathleen A. Hilliard, Laura J.H. Milgram, Michael W. Konstan, Mark R. Weather

Journal:

Pediatric Pulmonology

Year:

2002

Language:

english

File:

PDF, 202 KB

english, 2002

16

The authors reply

Richard C. Ahrens, Moira L. Aitken, Michael W. Konstan, Nael A. McCarty

Journal:

Pediatric Pulmonology

Year:

2002

Language:

english

File:

PDF, 23 KB

english, 2002

17

Standardized procedure for measurement of nasal potential difference: An outcome measure in multicenter cystic fibrosis clinical trials

Thomas A. Standaert, Louis Boitano, Julia Emerson, Laura J.H. Milgram, Michael W. Konstan, Janice Hunter, Pierre-Yves Berclaz, Lois Brass, Pamela L. Zeitlin, Keith Hammond, Zoe Davies, Carla Foy, Pead

Journal:

Pediatric Pulmonology

Year:

2004

Language:

english

File:

PDF, 172 KB

english, 2004

18

Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi-center study

Peadar G. Noone, Nicole Hamblett, Frank Accurso, Moira L. Aitken, Michael Boyle, Mark Dovey, Ron Gibson, Craig Johnson, Don Kellerman, Michael W. Konstan, Laura Milgram, Jean Mundahl, George Retsch-Bo

Journal:

Pediatric Pulmonology

Year:

2001

Language:

english

File:

PDF, 107 KB

english, 2001

19

Pulmonary exacerbations in cystic fibrosis

Harvey R. Rabin, Steven M. Butler, Mary Ellen B. Wohl, David E. Geller, Andrew A. Colin, Daniel V. Schidlow, Charles A. Johnson, Michael W. Konstan, Warren E. Regelmann

Journal:

Pediatric Pulmonology

Year:

2004

Language:

english

File:

PDF, 71 KB

english, 2004

20

Relation of sweat chloride concentration to severity of lung disease in cystic fibrosis

Pamela B. Davis, Mark D. Schluchter, Michael W. Konstan

Journal:

Pediatric Pulmonology

Year:

2004

Language:

english

File:

PDF, 83 KB

english, 2004

21

Beta 2 adrenergic receptor polymorphisms in cystic fibrosis

Meeghan A. Hart, Michael W. Konstan, Rebecca J. Darrah, Mark D. Schluchter, Amy Storfer-Isser, Lintong Xue, Douglas Londono, Katrina A.B. Goddard, Mitchell L. Drumm

Journal:

Pediatric Pulmonology

Year:

2005

Language:

english

File:

PDF, 85 KB

english, 2005

22

Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety

David E. Geller, Michael W. Konstan, Jeffrey Smith, Sarah B. Noonberg, Carol Conrad

Journal:

Pediatric Pulmonology

Year:

2007

Language:

english

File:

PDF, 123 KB

english, 2007

23

Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function

Clement L. Ren, Wayne J. Morgan, Michael W. Konstan, Michael S. Schechter, Jeffrey S. Wagener, Kathryn A. Fisher, Warren E. Regelmann

Journal:

Pediatric Pulmonology

Year:

2007

Language:

english

File:

PDF, 129 KB

english, 2007

24

Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis

Ronald L. Gibson, Julia Emerson, Nicole Mayer-Hamblett, Jane L. Burns, Sharon McNamara, Frank J. Accurso, Michael W. Konstan, Barbara A. Chatfield, George Retsch-Bogart, David A. Waltz, James Acton, P

Journal:

Pediatric Pulmonology

Year:

2007

Language:

english

File:

PDF, 186 KB

english, 2007

25

Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005

Donald R. VanDevanter, Lawrence Rasouliyan, Thomas M. Murphy, Wayne J. Morgan, Clement L. Ren, Michael W. Konstan, Jeffrey S. Wagener

Journal:

Pediatric Pulmonology

Year:

2008

Language:

english

File:

PDF, 127 KB

english, 2008

26

Dornase alfa and progression of lung disease in cystic fibrosis

Michael W. Konstan

Journal:

Pediatric Pulmonology

Year:

2008

Language:

english

File:

PDF, 124 KB

english, 2008

27

Shifting patterns of inhaled antibiotic use in cystic fibrosis

Samuel M. Moskowitz, Stefanie J. Silva, Nicole Mayer-Hamblett, David J. Pasta, David R. Mink, Jenny A. Mabie, Michael W. Konstan, Jeffrey S. Wagener

Journal:

Pediatric Pulmonology

Year:

2008

Language:

english

File:

PDF, 130 KB

english, 2008

28

Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis

Marci K. Sontag, Alexandra L. Quittner, Avani C. Modi, Joni M. Koenig, Don Giles, Christopher M. Oermann, Michael W. Konstan, Robert Castile, Frank J. Accurso

Journal:

Pediatric Pulmonology

Year:

2010

Language:

english

File:

PDF, 224 KB

english, 2010

29

Pulmonary outcome prediction (POP) tools for cystic fibrosis patients

Donald R. VanDevanter, Jeffrey S. Wagener, David J. Pasta, Eric Elkin, Joan R. Jacobs, Wayne J. Morgan, Michael W. Konstan

Journal:

Pediatric Pulmonology

Year:

2010

Language:

english

File:

PDF, 316 KB

english, 2010

30

Trends in the use of routine therapies in cystic fibrosis: 1995–2005

Michael W. Konstan, Donald R. VanDevanter, Lawrence Rasouliyan, David J. Pasta, Ashley Yegin, Wayne J. Morgan, Jeffrey S. Wagener

Journal:

Pediatric Pulmonology

Year:

2010

Language:

english

File:

PDF, 197 KB

english, 2010

31

Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: The EVOLVE trial

Michael W. Konstan, David E. Geller, Predrag Minić, Florian Brockhaus, Jie Zhang, Gerhild Angyalosi

Journal:

Pediatric Pulmonology

Year:

2011

Language:

english

File:

PDF, 396 KB

english, 2011

32

Clinical use of dornase alfa is associated with a slower rate of FEV1 decline in cystic fibrosis

Michael W. Konstan, Jeffrey S. Wagener, David J. Pasta, Stefanie J. Millar, Joan R. Jacobs, Ashley Yegin, Wayne J. Morgan, for the Scientific Advisory Group, the Investigators, Coordinators of the Epi

Journal:

Pediatric Pulmonology

Year:

2011

Language:

english

File:

PDF, 260 KB

english, 2011

33

Lung function decline from adolescence to young adulthood in cystic fibrosis

Stacy L. VandenBranden, Ann McMullen, Michael S. Schechter, David J. Pasta, Rory L. Michaelis, Michael W. Konstan, Jeffrey S. Wagener, Wayne J. Morgan, Susanna A. McColley, for the Investigators, Coor

Journal:

Pediatric Pulmonology

Year:

2012

Language:

english

File:

PDF, 144 KB

english, 2012

34

Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients

Mark D. Schluchter, Michael W. Konstan, Pamela B. Davis

Journal:

Statistics in Medicine

Year:

2002

Language:

english

File:

PDF, 155 KB

english, 2002

35

Book reviews

Loren J. Samons, Claude Mossé, Jonathan Barnes, David Konstan, Stephen T. Newmyer, Elaine Fantham, Heinz Heinen, Diana Delia, Alejandro G. Vigo, Angeliki E. Laiou, Constance B. Bouchard, Michael Ewans

Journal:

International Journal of the Classical Tradition

Year:

2000

Language:

english

File:

PDF, 3.72 MB

english, 2000

36

HIV Risk and the Internet: Results of the Men’s INTernet Sex (MINTS) Study

B. R. Simon Rosser, Michael H. Miner, Walter O. Bockting, Michael W. Ross, Joseph Konstan, Laura Gurak, Jeffrey Stanton, Weston Edwards, Scott Jacoby, Alex Carballo-Diéguez, Rafael Mazin, Eli Coleman

Journal:

AIDS and Behavior

Year:

2009

Language:

english

File:

PDF, 239 KB

english, 2009

37

HIV Sexual Risk Behavior by Men Who use the Internet to Seek Sex with Men: Results of the Men’s INTernet Sex Study-II (MINTS-II)

B. R. Simon Rosser, J. Michael Oakes, Keith J. Horvath, Joseph A. Konstan, Gene P. Danilenko, John L. Peterson

Journal:

AIDS and Behavior

Year:

2009

Language:

english

File:

PDF, 206 KB

english, 2009

38

The Future of Internet-Based HIV Prevention: A Report on Key Findings from the Men’s INTernet (MINTS-I, II) Sex Studies

B. R. Simon Rosser, J. Michael Wilkerson, Derek J. Smolenski, J. Michael Oakes, Joseph Konstan, Keith J. Horvath, Gunna R. Kilian, David S. Novak, Gene P. Danilenko, Richard Morgan

Journal:

AIDS and Behavior

Year:

2011

Language:

english

File:

PDF, 244 KB

english, 2011

39

Anti-inflammatory Therapies for Cystic Fibrosis-Related Lung Disease

David P. Nichols, Michael W. Konstan, James F. Chmiel

Journal:

Clinical Reviews in Allergy & Immunology

Year:

2008

Language:

english

File:

PDF, 354 KB

english, 2008

40

The role of inflammation in the pathophysiology of CF lung disease

James F. Chmiel, Melvin Berger, Michael W. Konstan

Journal:

Clinical Reviews in Allergy & Immunology

Year:

1992

Language:

english

File:

PDF, 204 KB

english, 1992

41

Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator Reconstitution

Konstan, Michael W., Davis, Pamela B., Wagener, Jeffrey S., Hilliard, Kathleen A., Stern, Robert C., Milgram, Laura J.H., Kowalczyk, Tomasz H., Hyatt, Susannah L., Fink, Tamara L., Gedeon, Christopher

Journal:

Human Gene Therapy

Year:

2004

Language:

english

File:

PDF, 208 KB

english, 2004

42

A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis

Michael S. Stalvey, Ran D. Anbar, Michael W. Konstan, Joan R. Jacobs, Bert Bakker, Barbara Lippe, David E. Geller

Journal:

Pediatric Pulmonology

Year:

2012

Language:

english

File:

PDF, 208 KB

english, 2012

43

Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosis

Susanna A. McColley, Clement L. Ren, Michael S. Schechter, Warren E. Regelmann, David J. Pasta, Michael W. Konstan, for the Investigators Coordinators of the Epidemiologic Study of Cystic Fibrosis

Journal:

Pediatric Pulmonology

Year:

2012

Language:

english

File:

PDF, 238 KB

english, 2012

44

Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis

Michael W. Konstan, Wayne J. Morgan, Steven M. Butler, David J. Pasta, Marcia L. Craib, Stefanie J. Silva, Dennis C. Stokes, Mary Ellen B. Wohl, Jeffrey S. Wagener, Warren E. Regelmann, Charles A. Joh

Journal:

The Journal of Pediatrics

Year:

2007

Language:

english

File:

PDF, 299 KB

english, 2007

45

Relationship between Inhaled Corticosteroid Therapy and Rate of Lung Function Decline in Children with Cystic Fibrosis

Clement L. Ren, David J. Pasta, Lawrence Rasouliyan, Jeffrey S. Wagener, Michael W. Konstan, Wayne J. Morgan

Journal:

The Journal of Pediatrics

Year:

2008

Language:

english

File:

PDF, 287 KB

english, 2008

46

Association of Socioeconomic Status with the Use of Chronic Therapies and Healthcare Utilization in Children with Cystic Fibrosis

Michael S. Schechter, Susanna A. McColley, Stefanie Silva, Tmirah Haselkorn, Michael W. Konstan, Jeffrey S. Wagener

Journal:

The Journal of Pediatrics

Year:

2009

Language:

english

File:

PDF, 189 KB

english, 2009

47

Socioeconomic Status and the Likelihood of Antibiotic Treatment for Signs and Symptoms of Pulmonary Exacerbation in Children with Cystic Fibrosis

Michael S. Schechter, Susanna A. McColley, Warren Regelmann, Stefanie J. Millar, David J. Pasta, Jeffrey S. Wagener, Michael W. Konstan, Wayne J. Morgan

Journal:

The Journal of Pediatrics

Year:

2011

Language:

english

File:

PDF, 138 KB

english, 2011

48

Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis

Michael W. Konstan, Pamela B. Davis

Journal:

Advanced Drug Delivery Reviews

Year:

2002

Language:

english

File:

PDF, 217 KB

english, 2002

49

The Challenges of Ensuring Participant Consent in Internet-based Sex Studies: A Case Study of the Men's INTernet Sex (MINTS-I and II) Studies

B. R. Simon Rosser, Laura Gurak, Keith J. Horvath, J. Michael Oakes, Joseph Konstan, Gene P. Danilenko

Journal:

Journal of Computer-Mediated Communication

Year:

2009

Language:

english

File:

PDF, 1.68 MB

english, 2009

50

Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis

Jeffrey S. Wagener, Lawrence Rasouliyan, Donald R. VanDevanter, David J. Pasta, Warren E. Regelmann, Wayne J. Morgan, Michael W. Konstan, for the Investigators, Coordinators of the Epidemiologic Study

Journal:

Pediatric Pulmonology

Year:

2012

Language:

english

File:

PDF, 194 KB

english, 2012